Tetramethylpyrazine ameliorates isoflurane‑induced cognitive dysfunction by inhibiting neuroinflammation via miR‑150 in rats

  • Authors:
    • Huaqing Cui
    • Zhonghui Xu
    • Chunshan Qu
  • View Affiliations

  • Published online on: August 7, 2020     https://doi.org/10.3892/etm.2020.9110
  • Pages: 3878-3887
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Tetramethylpyrazine (TMP) has neuroprotective effects in the pathogenesis of some human diseases, such as Parkinson's disease. The present study aimed to investigate the role of TMP in isoflurane‑induced cognitive dysfunction in rats, and further identify the mechanisms involved in the protective effects of TMP. The Morris water maze test was used to evaluate the cognitive function of rats exposed to isoflurane or treated with TMP. ELISA was conducted to evaluate the effects of isoflurane or TMP on neuroinflammation. The expression of microRNA‑150 (miR‑150) was measured using reverse transcription‑quantitative PCR, and the potential target genes of miR‑150 were predicted and verified. The impaired cognitive function induced by isoflurane in the rats was significantly ameliorated by treatment with TMP. In addition, TMP treatment in rats attenuated neuroinflammation caused by isoflurane. The expression of miR‑150 was inhibited by isoflurane exposure, but was enhanced by TMP treatment in rats. Furthermore, the overexpression of miR‑150 alleviated the isoflurane‑induced cognitive dysfunction and neuroinflammation, while the neuroprotective effects of TMP were significantly abrogated by the knockdown of miR‑150. AKT3 was a direct target of miR‑150, and its mRNA expression was significantly decreased by the overexpression of miR‑150 in isoflurane‑ and TMP‑treated rats. These results demonstrated the protective effects of TMP against isoflurane‑induced cognitive dysfunction, which were achieved by attenuating neuroinflammation via the regulation of the miR‑150/AKT3 pathway. In addition, miR‑150 may serve as a novel therapeutic target for the alleviation of cognitive dysfunction induced by anesthetics.
View Figures
View References

Related Articles

Journal Cover

October-2020
Volume 20 Issue 4

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Cui H, Xu Z and Qu C: Tetramethylpyrazine ameliorates isoflurane‑induced cognitive dysfunction by inhibiting neuroinflammation via miR‑150 in rats. Exp Ther Med 20: 3878-3887, 2020
APA
Cui, H., Xu, Z., & Qu, C. (2020). Tetramethylpyrazine ameliorates isoflurane‑induced cognitive dysfunction by inhibiting neuroinflammation via miR‑150 in rats. Experimental and Therapeutic Medicine, 20, 3878-3887. https://doi.org/10.3892/etm.2020.9110
MLA
Cui, H., Xu, Z., Qu, C."Tetramethylpyrazine ameliorates isoflurane‑induced cognitive dysfunction by inhibiting neuroinflammation via miR‑150 in rats". Experimental and Therapeutic Medicine 20.4 (2020): 3878-3887.
Chicago
Cui, H., Xu, Z., Qu, C."Tetramethylpyrazine ameliorates isoflurane‑induced cognitive dysfunction by inhibiting neuroinflammation via miR‑150 in rats". Experimental and Therapeutic Medicine 20, no. 4 (2020): 3878-3887. https://doi.org/10.3892/etm.2020.9110